Fibroblast growth factor receptor inhibitors: patent review (2015–2019)

Taylor and Francis Group, Expert Opinion on Therapeutic Patents, 12(29), p. 965-977, 2019

Journal article published in 2019 by Giuseppe Marseglia, Alessio Lodola

This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Preprint: archiving forbidden

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by